Share Prices & Company Research

Market News

26 Sep 2025 | 13:18

FTSE 250 movers: Oxford Biomedica tumbles on tariff sentiment

(Sharecast News) - FTSE 250 (MCX) 21,688.17 0.47% Oxford Biomedica shares slumped after US President Donald Trump announced a new raft of tariffs, including 100% on branded drugs.

Trump said the US would impose 100% levies on imported branded drugs, 25% on heavy-duty trucks and 50% on kitchen cabinets.

Bathroom vanities would be slapped with a 50% tariff while upholstered furniture would face duties of 30%.

All the new charges would take effect on October 1, Trump added via social media posts with exemptions for those companies that built factories in America.

Dr Martens led the risers, although there was no apparent reason for the jump.



FTSE 250 - Risers

Dr. Martens (DOCS) 94.65p 3.44% Johnson Service Group (JSG) 148.00p 3.21% Kier Group (KIE) 214.50p 3.13% Greggs (GRG) 1,556.00p 2.77% PayPoint (PAY) 668.00p 2.30% International Workplace Group (IWG) 215.00p 2.28% Grainger (GRI) 186.00p 2.09% THG (THG) 36.12p 2.03% Chemring Group (CHG) 564.00p 1.81% Raspberry PI Holdings (RPI) 419.30p 1.77%

FTSE 250 - Fallers

Oxford Biomedica (OXB) 537.00p -6.28% Ashoka India Equity Investment Trust (AIE) 259.50p -1.89% Pinewood Technologies Group (PINE) 426.50p -1.84% Victrex plc (VCT) 683.00p -1.73% Future (FUTR) 651.50p -1.66% Tate & Lyle (TATE) 451.60p -1.27% Hochschild Mining (HOC) 337.20p -1.06% JPMorgan Indian Investment Trust (JII) 1,014.00p -0.98% Templeton Emerging Markets Inv Trust (TEM) 216.00p -0.92% Pantheon Infrastructure (PINT) 108.00p -0.92%
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new portfolio or transferring your portfolio from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.